Global Cell and Advanced Therapies Supply Chain Management Market Growth (Status and Outlook) 2020-2025


Jun, 2020 | Report ID: 141085 | 130 | Pharmaceuticals and Healthcare

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Cell and Advanced Therapies Supply Chain Management will have significant change from previous year. By the most conservative estimates of global Cell and Advanced Therapies Supply Chain Management market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Cell and Advanced Therapies Supply Chain Management market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Advanced Therapies Supply Chain Management market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Cell and Advanced Therapies Supply Chain Management, covering the supply chain analysis, impact assessment to the Cell and Advanced Therapies Supply Chain Management market size growth rate in several scenarios, and the measures to be undertaken by Cell and Advanced Therapies Supply Chain Management companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

Cloud

On-premises

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

Biobank

Cell Therapy Lab

Hospital

Research Institute

Commercial Organization

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Be The Match BioTherapies

SAP

Brooks Life Sciences

Cryoport

Haemonetics

Clarkston Consulting

MAK-SYSTEM

Hypertrust Patient Data Care

MasterControl

Lykan Bioscience

TrakCel

Vineti

SAVSU Technologies

Title21 Health Solutions

Stafa Cellular Therapy

TraceLink

sedApta Group

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Cell and Advanced Therapies Supply Chain Management market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Cell and Advanced Therapies Supply Chain Management market by identifying its various subsegments.

Focuses on the key global Cell and Advanced Therapies Supply Chain Management players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Cell and Advanced Therapies Supply Chain Management with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Cell and Advanced Therapies Supply Chain Management submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

1.7 What is the Impact of Covid-19 Outbreak On the Cell and Advanced Therapies Supply Chain Management?

1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.

1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.

1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Cell and Advanced Therapies Supply Chain Management Market Size in 2020, by Scenario

1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cell and Advanced Therapies Supply Chain Management Market Size 2015-2025

2.1.2 Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Region

2.2 Cell and Advanced Therapies Supply Chain Management Segment by Type

2.2.1 Cloud

2.2.2 Cloud

2.3 Cell and Advanced Therapies Supply Chain Management Market Size by Type

2.3.1 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2015-2020)

2.3.2 Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Type (2015-2020)

2.4 Cell and Advanced Therapies Supply Chain Management Segment by Application

2.4.1 Biobank

2.4.2 Cell Therapy Lab

2.4.3 Hospital

2.4.4 Research Institute

2.4.5 Commercial Organization

2.5 Cell and Advanced Therapies Supply Chain Management Market Size by Application

2.5.1 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2015-2020)

2.5.2 Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Application (2015-2020)

3 Global Cell and Advanced Therapies Supply Chain Management by Players

3.1 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Players

3.1.1 Global Cell and Advanced Therapies Supply Chain Management Market Size by Players (2018-2020)

3.1.2 Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Players (2018-2020)

3.2 Global Cell and Advanced Therapies Supply Chain Management Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cell and Advanced Therapies Supply Chain Management by Regions

4.1 Cell and Advanced Therapies Supply Chain Management Market Size by Regions

4.2 Americas Cell and Advanced Therapies Supply Chain Management Market Size Growth

4.3 APAC Cell and Advanced Therapies Supply Chain Management Market Size Growth

4.4 Europe Cell and Advanced Therapies Supply Chain Management Market Size Growth

4.5 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Growth

5 Americas

5.1 Americas Cell and Advanced Therapies Supply Chain Management Market Size by Countries

5.2 Americas Cell and Advanced Therapies Supply Chain Management Market Size by Type

5.3 Americas Cell and Advanced Therapies Supply Chain Management Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Cell and Advanced Therapies Supply Chain Management Market Size by Regions

6.2 APAC Cell and Advanced Therapies Supply Chain Management Market Size by Type

6.3 APAC Cell and Advanced Therapies Supply Chain Management Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Cell and Advanced Therapies Supply Chain Management by Countries

7.2 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type

7.3 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management by Countries

8.2 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type

8.3 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Cell and Advanced Therapies Supply Chain Management Market Forecast

10.1 Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast (2021-2025)

10.2 Global Cell and Advanced Therapies Supply Chain Management Forecast by Regions

10.2.1 Global Cell and Advanced Therapies Supply Chain Management Forecast by Regions (2021-2025)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Cell and Advanced Therapies Supply Chain Management Forecast by Type

10.8 Global Cell and Advanced Therapies Supply Chain Management Forecast by Application

11 Key Players Analysis

11.1 Be The Match BioTherapies

11.1.1 Company Details

11.1.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.1.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.1.4 Main Business Overview

11.1.5 Be The Match BioTherapies News

11.2 SAP

11.2.1 Company Details

11.2.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.2.3 SAP Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.2.4 Main Business Overview

11.2.5 SAP News

11.3 Brooks Life Sciences

11.3.1 Company Details

11.3.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.3.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.3.4 Main Business Overview

11.3.5 Brooks Life Sciences News

11.4 Cryoport

11.4.1 Company Details

11.4.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.4.3 Cryoport Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.4.4 Main Business Overview

11.4.5 Cryoport News

11.5 Haemonetics

11.5.1 Company Details

11.5.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.5.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.5.4 Main Business Overview

11.5.5 Haemonetics News

11.6 Clarkston Consulting

11.6.1 Company Details

11.6.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.6.3 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.6.4 Main Business Overview

11.6.5 Clarkston Consulting News

11.7 MAK-SYSTEM

11.7.1 Company Details

11.7.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.7.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.7.4 Main Business Overview

11.7.5 MAK-SYSTEM News

11.8 Hypertrust Patient Data Care

11.8.1 Company Details

11.8.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.8.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.8.4 Main Business Overview

11.8.5 Hypertrust Patient Data Care News

11.9 MasterControl

11.9.1 Company Details

11.9.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.9.3 MasterControl Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.9.4 Main Business Overview

11.9.5 MasterControl News

11.10 Lykan Bioscience

11.10.1 Company Details

11.10.2 Cell and Advanced Therapies Supply Chain Management Product Offered

11.10.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2018-2020)

11.10.4 Main Business Overview

11.10.5 Lykan Bioscience News

11.11 TrakCel

11.12 Vineti

11.13 SAVSU Technologies

11.14 Title21 Health Solutions

11.15 Stafa Cellular Therapy

11.16 TraceLink

11.17 sedApta Group

12 Research Findings and Conclusion

List of Tables

Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Cell and Advanced Therapies Supply Chain Management Market Size in 2020, by Scenario

Table 2. COVID-19: Measures to be Undertaken by Cell and Advanced Therapies Supply Chain Management Companies

Table 3. Research Methodology

Table 4. Data Source

Table 5. Cell and Advanced Therapies Supply Chain Management Market Size CAGR by Region 2015-2025 ($ Millions)

Table 6. Major Players of Cloud

Table 7. Major Players of On-premises

Table 8. Cell and Advanced Therapies Supply Chain Management Market Size by Type (2014-2019) ($ Millions)

Table 9. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2015-2020)

Table 10. Global Cell and Advanced Therapies Supply Chain Management Market Size by Application (2015-2020) ($ Millions)

Table 11. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2015-2020)

Table 12. Global Cell and Advanced Therapies Supply Chain Management Revenue by Players (2018-2020) ($ Millions)

Table 13. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Players (2018-2020)

Table 14. Global Cell and Advanced Therapies Supply Chain Management Key Players Head office and Products Offered

Table 15. Cell and Advanced Therapies Supply Chain Management Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Cell and Advanced Therapies Supply Chain Management Market Size by Regions 2015-2020 ($ Millions)

Table 19. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Regions 2015-2020

Table 20. Americas Cell and Advanced Therapies Supply Chain Management Market Size by Countries (2015-2020) ($ Millions)

Table 21. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Countries (2015-2020)

Table 22. Americas Cell and Advanced Therapies Supply Chain Management Market Size by Type (2015-2020) ($ Millions)

Table 23. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2015-2020)

Table 24. Americas Cell and Advanced Therapies Supply Chain Management Market Size by Application (2015-2020) ($ Millions)

Table 25. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2015-2020)

Table 26. APAC Cell and Advanced Therapies Supply Chain Management Market Size by Regions (2015-2020) ($ Millions)

Table 27. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Regions (2015-2020)

Table 28. APAC Cell and Advanced Therapies Supply Chain Management Market Size by Type (2015-2020) ($ Millions)

Table 29. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2015-2020)

Table 30. APAC Cell and Advanced Therapies Supply Chain Management Market Size by Application (2015-2020) ($ Millions)

Table 31. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2015-2020)

Table 32. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Countries (2015-2020) ($ Millions)

Table 33. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Countries (2015-2020)

Table 34. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Type (2015-2020) ($ Millions)

Table 35. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2015-2020)

Table 36. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Application (2015-2020) ($ Millions)

Table 37. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2015-2020)

Table 38. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Countries (2015-2020) ($ Millions)

Table 39. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Countries (2015-2020)

Table 40. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Type (2015-2020) ($ Millions)

Table 41. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2015-2020)

Table 42. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Application (2015-2020) ($ Millions)

Table 43. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2015-2020)

Table 44. Key and Potential Regions of Cell and Advanced Therapies Supply Chain Management

Table 45. Key Application and Potential Industries of Cell and Advanced Therapies Supply Chain Management

Table 46. Key Challenges of Cell and Advanced Therapies Supply Chain Management

Table 47. Key Trends of Cell and Advanced Therapies Supply Chain Management

Table 48. Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Regions (2021-2025) ($ Millions)

Table 49. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share Forecast by Regions

Table 50. Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Type (2021-2025) ($ Millions)

Table 51. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share Forecast by Type (2021-2025)

Table 52. Global Cell and Advanced Therapies Supply Chain Management Market Size Forecast by Application (2021-2025) ($ Millions)

Table 53. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share Forecast by Application (2021-2025)

Table 54. Be The Match BioTherapies Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 55. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product Offered

Table 56. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 57. Be The Match BioTherapies Main Business

Table 58. Be The Match BioTherapies Latest Developments

Table 59. SAP Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 60. SAP Cell and Advanced Therapies Supply Chain Management Product Offered

Table 61. SAP Main Business

Table 62. SAP Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 63. SAP Latest Developments

Table 64. Brooks Life Sciences Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 65. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product Offered

Table 66. Brooks Life Sciences Main Business

Table 67. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 68. Brooks Life Sciences Latest Developments

Table 69. Cryoport Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 70. Cryoport Cell and Advanced Therapies Supply Chain Management Product Offered

Table 71. Cryoport Main Business

Table 72. Cryoport Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 73. Cryoport Latest Developments

Table 74. Haemonetics Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 75. Haemonetics Cell and Advanced Therapies Supply Chain Management Product Offered

Table 76. Haemonetics Main Business

Table 77. Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 78. Haemonetics Latest Developments

Table 79. Clarkston Consulting Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 80. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Product Offered

Table 81. Clarkston Consulting Main Business

Table 82. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 83. Clarkston Consulting Latest Developments

Table 84. MAK-SYSTEM Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 85. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product Offered

Table 86. MAK-SYSTEM Main Business

Table 87. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 88. MAK-SYSTEM Latest Developments

Table 89. Hypertrust Patient Data Care Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 90. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product Offered

Table 91. Hypertrust Patient Data Care Main Business

Table 92. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 93. Hypertrust Patient Data Care Latest Developments

Table 94. MasterControl Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 95. MasterControl Cell and Advanced Therapies Supply Chain Management Product Offered

Table 96. MasterControl Main Business

Table 97. MasterControl Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 98. MasterControl Latest Developments

Table 99. Lykan Bioscience Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 100. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product Offered

Table 101. Lykan Bioscience Main Business

Table 102. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue and Gross Margin (2018-2020E)

Table 103. Lykan Bioscience Latest Developments

Table 104. TrakCel Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 105. Vineti Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 106. SAVSU Technologies Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 107. Title21 Health Solutions Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 108. Stafa Cellular Therapy Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 109. TraceLink Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

Table 110. sedApta Group Details, Company Total Revenue (in $ million), Head Office, Cell and Advanced Therapies Supply Chain Management Major Market Areas and Its Competitors

List of Figures

Figure 1. Cell and Advanced Therapies Supply Chain Management Report Years Considered

Figure 2. Market Research Methodology

Figure 3. Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate 2015-2025 ($ Millions)

Figure 4. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2015-2020)

Figure 5. Global Cloud Market Size Growth Rate

Figure 6. Global On-premises Market Size Growth Rate

Figure 7. Cell and Advanced Therapies Supply Chain Management in Biobank

Figure 8. Global Cell and Advanced Therapies Supply Chain Management Market: Biobank (2015-2020) ($ Millions)

Figure 9. Cell and Advanced Therapies Supply Chain Management in Cell Therapy Lab

Figure 10. Global Cell and Advanced Therapies Supply Chain Management Market: Cell Therapy Lab (2015-2020) ($ Millions)

Figure 11. Cell and Advanced Therapies Supply Chain Management in Hospital

Figure 12. Global Cell and Advanced Therapies Supply Chain Management Market: Hospital (2015-2020) ($ Millions)

Figure 13. Global Hospital YoY Growth ($ Millions)

Figure 14. Cell and Advanced Therapies Supply Chain Management in Research Institute

Figure 15. Global Cell and Advanced Therapies Supply Chain Management Market: Research Institute (2015-2020) ($ Millions)

Figure 16. Global Research Institute YoY Growth ($ Millions)

Figure 17. Cell and Advanced Therapies Supply Chain Management in Commercial Organization

Figure 18. Global Cell and Advanced Therapies Supply Chain Management Market: Commercial Organization (2015-2020) ($ Millions)

Figure 19. Global Commercial Organization YoY Growth ($ Millions)

Figure 20. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2019

Figure 21. Global Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Regions 2015-2020

Figure 22. Americas Cell and Advanced Therapies Supply Chain Management Market Size 2015-2020 ($ Millions)

Figure 23. APAC Cell and Advanced Therapies Supply Chain Management Market Size 2015-2020 ($ Millions)

Figure 24. Europe Cell and Advanced Therapies Supply Chain Management Market Size 2015-2020 ($ Millions)

Figure 25. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size 2015-2020 ($ Millions)

Figure 26. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Countries in 2019

Figure 27. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2019

Figure 28. Americas Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2019

Figure 29. United States Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 30. Canada Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 31. Mexico Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 32. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Regions in 2019

Figure 33. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2019

Figure 34. APAC Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2019

Figure 35. China Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 36. Japan Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 37. Korea Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 38. Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 39. India Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 40. Australia Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 41. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Countries in 2019

Figure 42. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2019

Figure 43. Europe Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2019

Figure 44. Germany Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 45. France Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 46. UK Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 47. Italy Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 48. Russia Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 49. Spain Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 50. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Countries in 2019

Figure 51. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2019

Figure 52. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2019

Figure 53. Egypt Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 54. South Africa Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 55. Israel Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 56. Turkey Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 57. GCC Countries Cell and Advanced Therapies Supply Chain Management Market Size Growth 2015-2020 ($ Millions)

Figure 58. Global Cell and Advanced Therapies Supply Chain Management arket Size Forecast (2021-2025) ($ Millions)

Figure 59. Americas Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 60. APAC Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 61. Europe Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 62. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 63. United States Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 64. Canada Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 65. Mexico Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 66. Brazil Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 67. China Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 68. Japan Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 69. Korea Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 70. Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 71. India Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 72. Australia Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 73. Germany Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 74. France Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 75. UK Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 76. Italy Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 77. Russia Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 78. Spain Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 79. Egypt Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 80. South Africa Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 81. Israel Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 82. Turkey Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Figure 83. GCC Countries Cell and Advanced Therapies Supply Chain Management Market Size 2021-2025 ($ Millions)

Sample Request is not available